Uptake of Supportive Care Low for Patients With Advanced Cancer
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 28, 2025 -- Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care, according to a study published online Feb. 21 in JAMA Health Forum.
Youngmin Kwon, Ph.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues examined contemporary patterns of end-of-life care among patients with advanced cancer in a retrospective cohort study to determine whether efforts to improve end-of-life care among these patients in the last decade have had an impact. The study included 33,744 fee-for-service Medicare decedents aged 66 years or older who were originally diagnosed with distant-stage breast, prostate, pancreatic, or lung cancers and died between 2014 and 2019.
The researchers observed an increase in the mean number of acute care visits from six months before death to the month of death (from 14.0 to 46.2 per 100 person-months), as well as increases in hospice use (from 6.6 to 73.5 per 100 person-months), palliative care (from 2.6 to 26.1 per 100 person-months), and advanced care planning (from 1.7 to 12.8 per 100 person-months). Any indicator of potentially aggressive care was experienced by 45.0 percent of decedents in the last 30 days of life.
"We found that many patients continue to receive potentially aggressive interventions at end of life at the expense of supportive care services," the authors write. "To make meaningful improvements in the quality of end-of-life care, a multifaceted approach that addresses patient, physician, and system-level factors associated with persistent patterns of potentially aggressive care will be required."
One author disclosed ties to Pfizer.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
'Heart Age' Often Older Than Chronological Age
FRIDAY, Aug. 8, 2025 -- The Predicting Risk of Cardiovascular Disease Events (PREVENT) equation risk age is older than chronological age on average, with greater discordance for...
Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.